A highly informative CA/GT repeat polymorphism in intron 38 of the human neurofibromatosis type 1 (NF1) gene

1993 ◽  
Vol 92 (4) ◽  
pp. 429-430 ◽  
Author(s):  
Conxi L�zaro ◽  
Antonia Gaona ◽  
Ganfeng Xu ◽  
Robert Weiss ◽  
Xavier Estivill



Author(s):  
Nahla Abdel‐Aziz ◽  
Ghada El‐Kamah ◽  
Rabab Khairat ◽  
Hanan Mohamed ◽  
Yehia Gad ◽  
...  


1994 ◽  
Vol 94 (1) ◽  
pp. 97-100 ◽  
Author(s):  
Sven Hoffmeyer ◽  
Günter Assum ◽  
Dieter Kaufmann ◽  
Kirsten Schwenk ◽  
Winfrid Krone


1997 ◽  
Vol 99 (5) ◽  
pp. 674-676 ◽  
Author(s):  
Julie Maynard ◽  
Michael Krawczak ◽  
M. Upadhyaya


1993 ◽  
Vol 2 (4) ◽  
pp. 439-444 ◽  
Author(s):  
David I. Rodenhiser ◽  
Marion B. Coulter-Mackie ◽  
Shiva M. Singh


2010 ◽  
Vol 27 (4) ◽  
pp. 635-638
Author(s):  
Anna Lia Gabriele ◽  
Martino Ruggieri ◽  
Alessandra Patitucci ◽  
Angela Magariello ◽  
Francesca Luisa Conforti ◽  
...  


2018 ◽  
Vol 33 (5) ◽  
pp. 1443-1457 ◽  
Author(s):  
Ashish Kumar Agrahari ◽  
Meghana Muskan ◽  
C. George Priya Doss ◽  
R. Siva ◽  
Hatem Zayed


2019 ◽  
Vol 2 (Supplement_1) ◽  
pp. i33-i39
Author(s):  
Cheng-Jiang Wei ◽  
Shu-Chen Gu ◽  
Jie-Yi Ren ◽  
Yi-Hui Gu ◽  
Xiang-Wen Xu ◽  
...  

Abstract AbstractThe immune system plays an essential role in the development of tumors, which has been demonstrated in multiple types of cancers. Consistent with this, immunotherapies with targets that disrupt these mechanisms and turn the immune system against developing cancers have been proven effective. In neurofibromatosis type 1 (NF1), an autosomal dominant genetic disorder, the understanding of the complex interactions of the immune system is incomplete despite the discovery of the pivotal role of immune cells in the tumor microenvironment. Individuals with NF1 show a loss of the NF1 gene in nonneoplastic cells, including immune cells, and the aberrant immune system exhibits intriguing interactions with NF1. This review aims to provide an update on recent studies showing the bilateral influences of NF1 mutations on immune cells and how the abnormal immune system promotes the development of NF1 and NF1-related tumors. We then discuss the immune receptors major histocompatibility complex class I and II and the PD-L1 mechanism that shield NF1 from immunosurveillance and enable the immune escape of tumor tissues. Clarification of the latest understanding of the mechanisms underlying the effects of the abnormal immune system on promoting the development of NF1 will indicate potential future directions for further studies and new immunotherapies.



2000 ◽  
Vol 16 (3) ◽  
pp. 274-275 ◽  
Author(s):  
E. Girodon Boulandet ◽  
J. Pantel ◽  
C. Cazeneuve ◽  
M. Van Gijn ◽  
D. Vidaud ◽  
...  


Sign in / Sign up

Export Citation Format

Share Document